AIDS News and Research

RSS

FDA approves the usage of Valcyte for preventing CMV disease in pediatric patients

Roche announced today that the U.S. Food and Drug Administration (FDA) has approved Valcyte(R) (valganciclovir hydrochloride) for the prevention of cytomegalovirus (CMV) disease in pediatric kidney and heart transplant patients (4 months to 16 years of age) at high risk of developing CMV disease.

31 Aug 2009

High incidence of HIV infection is found among South African gays

New research from UCSF examining HIV among men who have sex with men (MSM) in the township of Soweto in South Africa has found that a third of gay-identified men are infected with HIV.

31 Aug 2009

Foresight integrates eEmergence's HIPAA 5010 interpretive content into its products

Foresight Corporation, the nation’s leading provider of transaction processing automation solutions for healthcare, announced today the integration of eEmergence, Inc.’s exclusive HIPAA 5010 interpretive content into selected products, a move that will facilitate 5010 migration for Foresight’s customers.

29 Aug 2009

BioAlliance Pharma to discuss nanoparticle technology and its therapeutic applications at the French-Norwegian Interdisciplinary Symposium

BioAlliance Pharma SA, a company dedicated to the treatment and supportive care of cancer and AIDS patients, today announced that it will present its nanoparticle technology and the latter's advantages in therapeutic applications at the French-Norwegian Interdisciplinary Symposium on Nano and Micro Frontiers in Biology and Medicine, to take place in Bergen, Norway, from August 31 to September 2, 2009.

29 Aug 2009

Pressure on G20 leader to tax financial transactions for aid money intensifies

G20 finance ministers meeting in London next Friday, ahead of a G20 meeting in Pittsburgh, "will face concerted pressure to introduce a tax on financial transactions as a coalition of anti-poverty campaigners aim to force the issue onto the agenda," the Guardian reports.

29 Aug 2009

Also in Global Health news: ARVs in Uganda; Brazil's fight against HIV/AIDS

Zainab Akol, Uganda's AIDS Control Program director, said the health ministry has acquired enough antiretroviral (ARV) drugs to provide treatment for people living with HIV/AIDS until the end of the year, New Vision reports. In addition to 30 tons of drugs, the ministry received at the beginning of August from the Global Fund to Fight AIDS, Tuberculosis and Malaria, it also purchased ARVs worth about $20 million this month, Akol said (Kagolo, 8/27).

29 Aug 2009

HIV subtype D infected patients more likely to develop dementia

Patients infected with a particular subtype of HIV, the virus that causes AIDS, are more likely to develop dementia than patients with other subtypes, a study led by Johns Hopkins researchers shows. The finding, reported in the September Clinical Infectious Diseases, is the first to demonstrate that the specific type of HIV has any effect on cognitive impairment, one of the most common complications of uncontrolled HIV infection.

28 Aug 2009

Former President Bill Clinton to be the keynote speaker at the Annual Speaker Series Luncheon

Chicago House & Social Service Agency, the first organization in the Midwest to provide housing and support for people living with HIV and AIDS, will host their first ever Speaker Series Luncheon on November 11, 2009, welcoming President Bill Clinton as the keynote speaker.

28 Aug 2009

WTN Services and Winetasting Network to be lead corporate sponsors of the Annual AIDS Walk Napa Valley

WTN Services(R) and the Winetasting Network(R) a division of 1-800-Flowers.com(R) have announced they have deepened the commitment to their existing plan of industry partnerships and projects that better the community.

28 Aug 2009

NIMH grants Xhale $1.7 million to develop the SMART medication adherence system for HIV/AIDS therapies

Xhale, Inc. has been awarded a $1.7 million Small Business Innovation Research (SBIR) Phase II grant by the NIH National Institute of Mental Health (NIMH) to continue the development of SMART (Self Monitoring and Reporting Therapeutics), a breath-based medication adherence system for HIV/AIDS therapies.

28 Aug 2009

Cardea and Optasia to collaborate on configuring their Vertebral Fracture Assessment software tools

Cardea Technology, Inc. and Optasia Medical Ltd., announce plans to collaborate and configure their software tools for Vertebral Fracture Assessment, a method for evaluating vertebral fractures from images on bone densitometers, to exchange information and create reports for the management of osteoporosis.

28 Aug 2009

Also in global health news: NTD study; false cholera cases in Zimbabwe; contaminated water in Kenya; doctor's strike ends

UPI reports on a recent review article in the journal PLoS Neglected Tropical Diseases that analyzed the toll of neglected tropical diseases on populations in sub-Saharan Africa. "Researchers said helminth (parasitic worm) infections account for approximately 85 percent of the neglected tropical diseases, which overall might be equivalent to more than double that caused by tuberculosis and as much as half of the area's malaria disease burden," the news service writes (8/26).

28 Aug 2009

First Edition: August 27, 2009

Today's news: Speculation begins regarding the impact Sen. Kennedy's death will have on the health reform debate and the Democrat's prospects for success.

27 Aug 2009

Viral Genetics cautions investors and the public to rely only on its own releases and disclosures

Viral Genetics (Pink Sheets: VRAL), a biotechnology company that develops drug compounds for HIV/AIDS, autoimmune diseases, and cancer, is issuing this announcement in response to a series of press releases distributed by collegestock.com on August 25 and August 26, and an article published on Today's Financial News entitled "TFN Reader Grapevine: There's Something About Viral Genetics, Inc. (VRAL)," on August 25.

27 Aug 2009

Movember to present at the LIVESTRONG Global Cancer Summit

Staggering statistic: cancer kills more people every year than AIDS, tuberculosis and malaria combined. Joining more than 250 advocates from around the world, Adam Garone, co-founder and CEO of Movember, the world's largest charity for men's health, will present at the LIVESTRONG Global Cancer Summit in Dublin, Ireland, August 24 - 26.

27 Aug 2009

EDCTP welcomes proposals for tuberculosis vaccines and HIV/AIDS treatment projects

EDCTP welcomes project proposals as a response to the following calls: Tuberculosis vaccines, HIV/AIDS treatment and Member States Initiated projects.

27 Aug 2009

Sen. Edward M. Kennedy -- health care champion -- dies

Sen. Edward M. Kennedy had a hand in nearly every piece of health care legislation that moved through Congress during his eight-term Senate tenure. He died Tuesday night of brain cancer at age 77.

27 Aug 2009

Briggs introduces a new program to improve quality of healthcare in nursing homes

Briggs, the company known for over 60 years as a trusted provider of documentation solutions to long term care facilities, today announced a unique program to improve the quality of care in the nation's 14,000 Medicare and Medicaid certified nursing homes.

27 Aug 2009

BioAlliance Pharma posts revenue of €4.1 million for the first half of 2009

BioAlliance Pharma SA (Paris:BIO) (Euronext Paris – BIO), a company dedicated to the treatment and supportive care of cancer and AIDS patients, today presented its consolidated half-year accounts to June 30, 2009.

27 Aug 2009

Council for American Medical Innovation mourns the death of Senator Edward M. Kennedy

The Council for American Medical Innovation joins with members of the health community in mourning the loss of Senator Edward M. Kennedy, one of America's foremost advocates for all health care causes, particularly the medically underserved. His work in advancing medical innovation has left an indelible mark on the innovation space and transformed America's ability to invest in cures for illnesses that affect patients around the world.

27 Aug 2009

AIDS News and Research

FDA approves the usage of Valcyte for preventing CMV disease in pediatric patients

High incidence of HIV infection is found among South African gays

Foresight integrates eEmergence's HIPAA 5010 interpretive content into its products

BioAlliance Pharma to discuss nanoparticle technology and its therapeutic applications at the French-Norwegian Interdisciplinary Symposium

Pressure on G20 leader to tax financial transactions for aid money intensifies

Also in Global Health news: ARVs in Uganda; Brazil's fight against HIV/AIDS

HIV subtype D infected patients more likely to develop dementia

Former President Bill Clinton to be the keynote speaker at the Annual Speaker Series Luncheon

WTN Services and Winetasting Network to be lead corporate sponsors of the Annual AIDS Walk Napa Valley

NIMH grants Xhale $1.7 million to develop the SMART medication adherence system for HIV/AIDS therapies

Cardea and Optasia to collaborate on configuring their Vertebral Fracture Assessment software tools

Also in global health news: NTD study; false cholera cases in Zimbabwe; contaminated water in Kenya; doctor's strike ends

First Edition: August 27, 2009

Viral Genetics cautions investors and the public to rely only on its own releases and disclosures

Movember to present at the LIVESTRONG Global Cancer Summit

EDCTP welcomes proposals for tuberculosis vaccines and HIV/AIDS treatment projects

Sen. Edward M. Kennedy -- health care champion -- dies

Briggs introduces a new program to improve quality of healthcare in nursing homes

BioAlliance Pharma posts revenue of €4.1 million for the first half of 2009

Council for American Medical Innovation mourns the death of Senator Edward M. Kennedy

Industry Focus eBook - Analytical Chemistry (2nd Edition) eBook

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Latest News